No Data
Express News | Ocuphire Pharma Participates In ARVO SIG Panel And ASRS 42nd Annual Scientific Meeting To Highlight APX3330 For Diabetic Retinopathy
Express News | Ocuphire Pharma Announces Upcoming Presentations On Lead Candidate APX3330 For Diabetic Retinopathy At Clinical Trials At The Summit On June 8 And Retinal Imaging Biomarkers & Endpoints Summit June 25-27
Ocuphire Pharma(OCUP.US) Officer Buys US$6,177.5 in Common Stock
$Ocuphire Pharma(OCUP.US)$ Officer Jayagopal Ashwath purchased 3,500 shares of common stock on May 22, 2024 at an average price of $1.765 for a total value of $6,177.5.Source: Announcement What is sta
Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed higher by 0.2% on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested i
Ocuphire Pharma(OCUP.US) Officer Buys US$8,772.5 in Common Stock
$Ocuphire Pharma(OCUP.US)$ Officer Magrath George purchased 5,000 shares of common stock on May 17, 2024 at an average price of $1.7545 for a total value of $8,772.5.Source: Announcement What is state
Ocuphire Pharma Is Maintained at Buy by Canaccord Genuity
Ocuphire Pharma Is Maintained at Buy by Canaccord Genuity
mohammad ahmady : y